Scott Cathcart, co-founder and CEO of Seven-10 Pharmaceuticals, was interviewed at Benzinga’s Cannabis Capital Conference. The company recently got its cannabis pharmaceutical license and is now sending shipments to Brazil, representing a large expansion into a big market. They are also expanding into other international markets in addition to having operations in the United States. Cathcart shared that with international regulations always changing, being flexible is essential to succeeding in the industry.
Watch Exclusive Footage Here
Interested in learning more about the Benzinga Cannabis Capital Conference? Get more information here
This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.